NEEDHAM, Mass., April 3, 2026
Trialt, a global clinical research organization (CRO), has announced a strategic collaboration with Viedoc, a leading provider of cloud-based eClinical solutions, to enhance the efficiency, speed, and data quality of clinical trials through connected data and biometrics integration. This partnership reflects a growing shift toward digital transformation in clinical research, where real-time data access, integrated analytics, and streamlined workflows are becoming essential for improving trial outcomes and regulatory success. By combining advanced electronic data capture (EDC) platforms with deep biometrics expertise, the collaboration aims to create a fully connected clinical trial ecosystem that accelerates decision-making and reduces operational complexity.
Connected Data Platforms Enhance Trial Efficiency
At the core of this collaboration is Viedoc’s cloud-based eClinical platform, which unifies data capture, management, and reporting into a single integrated system, enabling sponsors and CROs to conduct more efficient, transparent, and compliant clinical trials. The platform supports low-code study design, allowing faster study setup and deployment while maintaining full visibility into operational and clinical data in real time.
Its electronic data capture (EDC) capabilities, combined with built-in validation, audit trails, and global regulatory compliance, ensure high-quality, reliable data from the outset. By connecting multiple data sources into a unified system, the platform helps reduce fragmentation, enabling better coordination across global and decentralized trials, which are increasingly common in modern clinical research.
Biometrics Integration Drives Faster Decision-Making
Advertisement
The collaboration leverages Trialt’s expertise in biometrics, statistical programming, and data analysis, ensuring that clinical data flows seamlessly from collection to interpretation and regulatory submission. This integration is critical in reducing delays caused by data inconsistencies, rework, and fragmented systems, which are common challenges in traditional trial models. By aligning data capture with downstream analytics early in the study lifecycle, the partnership enables sponsors to identify trends faster, make informed decisions, and accelerate timelines.
This approach also supports higher data integrity and improved statistical accuracy, which are essential for meeting regulatory requirements and achieving successful trial outcomes. The result is a more agile and responsive clinical development process, where data insights can be translated into action with minimal delay.
Advancing Digital Transformation in Clinical Research
The collaboration between Trialt and Viedoc underscores the increasing importance of digital health technologies and integrated data ecosystems in clinical trials, particularly as the industry shifts toward decentralized and global study models. By combining technology-driven data capture with advanced biometrics capabilities, the partnership aims to create a more connected and efficient clinical trial experience, reducing operational bottlenecks and improving overall study performance.
This integrated model allows research teams to focus more on scientific outcomes and less on operational challenges, ultimately accelerating the development of new therapies and medical innovations. As clinical trials become more complex and data-intensive, solutions that enable seamless data integration, real-time analytics, and regulatory compliance will play a critical role in shaping the future of clinical research and drug development.
With this strategic collaboration, Trialt and Viedoc are positioning themselves at the forefront of digital clinical trial innovation, delivering a data-driven, technology-enabled approach that enhances efficiency, data quality, and decision-making, while supporting the broader goal of bringing life-changing treatments to patients faster and more effectively.
Source: Trialt, Viedoc press release
